Skip to main content
TipRanks
Go Ultimate75% OFF
Nanopath logo

Nanopath: Valuation, Funding & Investors

Nanopath is a point-of-care diagnostics company developing molecular testing technologies that deliver laboratory-quality results in minutes. Its platform focuses on women's health testing, including vaginitis, with potential expansion into urinary tract and sexually transmitted infection diagnostics.

Leadership & Board

Latest Estimated Valuation

Total Amount Raised
$25M
Total Funding Rounds
1
Latest Funding Amount
$25M
Latest Funding Round
Series B

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Nov 10, 2026Series B$25.00M―

Related News and Analysis